Showing results for #MaternalMentalHealth
Browse our latest mental health blogs. Use # to search hashtags (partial match), or type any words to match blog titles.
FDA Approves First Treatment for Postpartum Depression: Brexanolone
In a groundbreaking development for maternal mental health, the FDA has approved Brexanolone (Zulresso), the first medication specifically designed to treat postpartum depression (PPD). This approval marks a significant advancement in addressing a condition that affects many new mothers, providing a new avenue of hope and recovery.
By Dr. Jash Ajmera
Mon Feb 03 2025